Literature DB >> 18040720

Infection of immunocompetent mice with acid-water-pretreated Cryptosporidium parvum results in weight loss, and intestinal (structural and physiological) alterations.

Armandina Garza1, Alejandro Castellanos-Gonzalez, Alejandro Castenallos-Gonzalez, Jeffrey Griffiths, Prema Robinson.   

Abstract

Cryptosporidiosis, caused by Cryptosporidium, causes self-limited diarrhea in normal hosts but may cause life-threatening diarrhea in immunocompromised persons. Cryptosporidium-induced manifestations, including weight-loss and intestinal physiological alterations are not noted in adult immunocompetent mice. So far, studies that have been used to test the therapeutic efficacy of drugs have been performed using various immunocompromised animal models. There is an urgent need of an immunocompetent small animal model that portrays Cryptosporidium-induced manifestations. In the current studies, we have compared two Cryptosporidium parvum pretreatment methods, we have hence used sodium hypochlorite or acidic water to treat Cryptosporidium parvum, followed by infection by oral gavage in adult immunocompetent C57BL6 mice. We demonstrated manifestations such as weight loss, intestinal structural and physiological alterations such as intestinal, villi blunting, and glucose malabsorption (as studied by the Ussing chamber technique) only in response to infection with C. parvum that has been treated with acidic water and not with sodium hypochlorite. These novel studies reveal that acidic water treatment of C. parvum results in manifestations of cryptosporidiosis in otherwise resistant immunocompetent mice. The current studies open up possibilities of using the normal immunocompetent mice model to test therapeutic drugs against cryptosporidiosis.

Entities:  

Mesh:

Year:  2007        PMID: 18040720     DOI: 10.1007/s00436-007-0785-3

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  26 in total

1.  Chemical and physical factors affecting the excystation of Cryptosporidium parvum oocysts.

Authors:  S Kato; M B Jenkins; W C Ghiorse; D D Bowman
Journal:  J Parasitol       Date:  2001-06       Impact factor: 1.276

2.  Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice.

Authors:  J R Mead; M J Arrowood; R W Sidwell; M C Healey
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  Effect of interferon-gamma in experimental Cryptosporidium parvum infection.

Authors:  J E Rehg
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

4.  Infection of immunosuppressed C57BL/6N adult mice with a single oocyst of Cryptosporidium parvum.

Authors:  S Yang; S K Benson; C Du; M C Healey
Journal:  J Parasitol       Date:  2000-08       Impact factor: 1.276

5.  Dietary nucleosides and nucleotides reduce Cryptosporidium parvum infection in dexamethasone immunosuppressed adult mice.

Authors:  A A Adjei; J T Jones; F J Enriquez; S Yamamoto
Journal:  Exp Parasitol       Date:  1999-07       Impact factor: 2.011

6.  Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice.

Authors:  M Cosyns; S Tsirkin; M Jones; R Flavell; H Kikutani; A R Hayward
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Characterization of experimental Cryptosporidium parvum infection in IFN-gamma knockout mice.

Authors:  X You; J R Mead
Journal:  Parasitology       Date:  1998-12       Impact factor: 3.234

8.  Changes in mouse circulating leukocyte numbers in C57BL/6 mice immunosuppressed with dexamethasone for Cryptosporidium parvum oocyst production.

Authors:  Thomas A Miller; Frank W Schaefer
Journal:  Vet Parasitol       Date:  2007-09-27       Impact factor: 2.738

9.  Development of cellular immune functions in neonatal to weanling mice: relationship to Cryptosporidium parvum infection.

Authors:  J A Harp; R E Sacco
Journal:  J Parasitol       Date:  1996-04       Impact factor: 1.276

10.  Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection.

Authors:  S A Aguirre; P H Mason; L E Perryman
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.